North Star Investment Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-250
| Closed | -$330 | – | 1287 |
|
|
2024
Q3 | $330 | Hold |
250
| – | – | ﹤0.01% | 1142 |
|
|
2024
Q2 | $1.9K | Hold |
250
| – | – | ﹤0.01% | 1041 |
|
|
2024
Q1 | $2.25K | Hold |
250
| – | – | ﹤0.01% | 1078 |
|
|
2023
Q4 | $2.68K | Sell |
250
-250
| -50% | -$2.68K | ﹤0.01% | 1019 |
|
|
2023
Q3 | $3K | Buy |
500
+250
| +100% | +$1.5K | ﹤0.01% | 1026 |
|
|
2023
Q2 | $1.73K | Hold |
250
| – | – | ﹤0.01% | 1088 |
|
|
2023
Q1 | $3.93K | Hold |
250
| – | – | ﹤0.01% | 1012 |
|
|
2022
Q4 | $5K | Hold |
250
| – | – | ﹤0.01% | 971 |
|
|
2022
Q3 | $4K | Hold |
250
| – | – | ﹤0.01% | 979 |
|
|
2022
Q2 | $6K | Hold |
250
| – | – | ﹤0.01% | 923 |
|
|
2022
Q1 | $7K | Hold |
250
| – | – | ﹤0.01% | 940 |
|
|
2021
Q4 | $11K | Hold |
250
| – | – | ﹤0.01% | 895 |
|
|
2021
Q3 | $21K | Hold |
250
| – | – | ﹤0.01% | 736 |
|
|
2021
Q2 | $24K | Hold |
250
| – | – | ﹤0.01% | 717 |
|
|
2021
Q1 | $42K | Hold |
250
| – | – | ﹤0.01% | 584 |
|
|
2020
Q4 | $24K | Buy |
250
+50
| +25% | +$4.8K | ﹤0.01% | 663 |
|
|
2020
Q3 | $7K | Hold |
200
| – | – | ﹤0.01% | 814 |
|
|
2020
Q2 | $11K | Hold |
200
| – | – | ﹤0.01% | 713 |
|
|
2020
Q1 | $12K | Sell |
200
-45
| -18% | -$2.7K | ﹤0.01% | 706 |
|
|
2019
Q4 | $19K | Hold |
245
| – | – | ﹤0.01% | 721 |
|
|
2019
Q3 | $24K | Buy |
+245
| New | +$24K | ﹤0.01% | 688 |
|